Search
Karyopharm Therapeutics Inc
KPTIAdd to Watchlist
9.020USD
-0.380-4.04%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
165.17MMarket Cap
LossP/E TTM
Karyopharm Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Karyopharm Therapeutics Inc is 8.82, ranking 66 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -0.56, which is -54.29% below the recent high of -0.25 and -360.84% above the recent low of -2.57.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
